Effect of electroacupuncture on liver Akt/FoxO1 signaling pathway in rats with diabetic fatty.
10.13703/j.0255-2930.20220505-k0006
- Author:
Ying DONG
1
;
Rui LI
1
;
Wei-Xing GUO
1
;
Fang-Fang MO
2
;
Shan-Shan SONG
1
;
Hao-Ru DUAN
1
;
Shu-Ting ZHUANG
1
;
Meng-Wei GUO
1
Author Information
1. College of Acupuncture-Moxibustion and Tuina, Beijing University of CM, Beijing 102401, China.
2. College of TCM, Beijing University of CM, Beijing 102401, China.
- Publication Type:Journal Article
- Keywords:
electroacupuncture;
forkhead box transcription factor 1 (FoxO1);
insulin resistance;
phosphoenolpyruvate carboxykinase (PEPCK);
protein kinase B (Akt);
type 2 diabetes mellitus
- MeSH:
Male;
Animals;
Rats;
Rats, Zucker;
Proto-Oncogene Proteins c-akt/genetics*;
Diabetes Mellitus, Type 2/therapy*;
Insulin Resistance;
C-Peptide;
Electroacupuncture;
Liver;
Signal Transduction;
Insulin;
Lipids
- From:
Chinese Acupuncture & Moxibustion
2023;43(6):679-683
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the effect of electroacupuncture (EA) on liver protein kinase B (Akt)/forkhead box transcription factor 1 (FoxO1) signaling pathway in Zucker diabetic fatty (ZDF) rats, and to explore the possible mechanism of EA on improving liver insulin resistance of type 2 diabetes mellitus.
METHODS:Twelve male 2-month-old ZDF rats were fed with high-fat diet for 4 weeks to establish diabetes model. After modeling, the rats were randomly divided into a model group and an EA group, with 6 rats in each group. In addition, six male Zucker lean (ZL) rats were used as the blank group. The rats in the EA group were treated with EA at bilateral "Zusanli" (ST 36), "Sanyinjiao" (SP 6), "Weiwanxiashu" (EX-B 3), and "Pishu" (BL 20). The ipsilateral "Zusanli" (ST 36) and "Weiwanxiashu" (EX-B 3) were connected to EA device, continuous wave, frequency of 15 Hz, 20 min each time, once a day, six times a week, for a total of 4 weeks. The fasting blood glucose (FBG) in each group was compared before modeling, before intervention and after intervention; the serum levels of insulin (INS) and C-peptide were measured by radioimmunoassay method, and the insulin resistance index (HOMA-IR) was calculated; HE staining method was used to observe the liver tissue morphology; Western blot method was used to detect the protein expression of Akt, FoxO1 and phosphoenolpyruvate carboxykinase (PEPCK) in the liver.
RESULTS:Before intervention, compared with the blank group, FBG was increased in the model group and the EA group (P<0.01); after intervention, compared with the model group, FBG in the EA group was decreased (P<0.01). Compared with the blank group, the serum levels of INS and C-peptide, HOMA-IR, and the protein expression of hepatic FoxO1 and PEPCK were increased (P<0.01), while the protein expression of hepatic Akt was decreased (P<0.01) in the model group. Compared with the model group, the serum levels of INS and C-peptide, HOMA-IR, and the protein expression of hepatic FoxO1 and PEPCK were decreased (P<0.01), while the protein expression of hepatic Akt was increased (P<0.01) in the EA group. In the model group, the hepatocytes were structurally disordered and randomly arranged, with a large number of lipid vacuoles in the cytoplasm. In the EA group, the morphology of hepatocytes tended to be normal and lipid vacuoles were decreased.
CONCLUSION:EA could reduce FBG and HOMA-IR in ZDF rats, improve liver insulin resistance, which may be related to regulating Akt/FoxO1 signaling pathway.
